We are live on ! Find out more
DARE icon

Dare Bioscience

19 hedge funds and large institutions have $1.61M invested in Dare Bioscience in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,063% more capital inflows, than outflows

Capital inflows: $773K | Capital outflows: $66.5K

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

2.29% more ownership

Funds ownership: 3.81% → 6.1% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 21 → 19 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
5
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DARE Hedge Fund Activity: Q2 2020 in Review

19 of the 4,891 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2020, worth a combined $1.61M — up 102% from $798K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of DARE and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $461K. The largest seller was UBS Group, cutting an estimated $38.8K.

  • 19 institutional investors held Dare Bioscience (DARE) as of Q2 2020, down from 21 in Q1 2020.
  • Funds reported $1.61M of Dare Bioscience stock for Q2 2020, up 102% quarter-over-quarter.
  • 2 funds opened new Dare Bioscience positions in Q2 2020 and 4 closed out, a net change of -2 holders.
  • The largest Dare Bioscience buyer in Q2 2020 was Renaissance Technologies, an estimated $461K added.
  • The largest Dare Bioscience seller in Q2 2020 was UBS Group, an estimated $38.8K sold.

Based on aggregated 13F filings for Q2 2020.